GIANSANTE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 6.814
EU - Europa 3.542
AS - Asia 2.674
SA - Sud America 242
AF - Africa 71
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.366
Nazione #
US - Stati Uniti d'America 6.714
IT - Italia 1.375
SG - Singapore 997
CN - Cina 709
SE - Svezia 422
UA - Ucraina 376
DE - Germania 337
VN - Vietnam 225
HK - Hong Kong 219
BR - Brasile 195
FR - Francia 178
GB - Regno Unito 171
FI - Finlandia 169
RU - Federazione Russa 153
KR - Corea 150
TR - Turchia 118
BD - Bangladesh 84
PL - Polonia 83
IE - Irlanda 64
BG - Bulgaria 62
IN - India 60
CA - Canada 59
NL - Olanda 44
BE - Belgio 26
MA - Marocco 20
MX - Messico 19
AR - Argentina 18
ES - Italia 18
JP - Giappone 18
SN - Senegal 18
AU - Australia 14
CH - Svizzera 13
IQ - Iraq 12
PK - Pakistan 11
ID - Indonesia 10
KE - Kenya 10
AT - Austria 9
TH - Thailandia 9
ZA - Sudafrica 9
EC - Ecuador 8
CZ - Repubblica Ceca 7
CO - Colombia 6
LT - Lituania 6
PH - Filippine 6
VE - Venezuela 6
EU - Europa 5
JO - Giordania 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DK - Danimarca 4
EG - Egitto 4
SA - Arabia Saudita 4
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
PT - Portogallo 3
RO - Romania 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
IL - Israele 2
KH - Cambogia 2
KW - Kuwait 2
LC - Santa Lucia 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
UG - Uganda 2
UZ - Uzbekistan 2
AL - Albania 1
AW - Aruba 1
BB - Barbados 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
Totale 13.357
Città #
Woodbridge 867
Ann Arbor 699
Ashburn 603
Fairfield 585
Singapore 561
Houston 504
Chandler 428
Jacksonville 337
San Jose 296
Wilmington 274
Seattle 256
Hong Kong 213
Cambridge 208
Hefei 162
Beijing 159
Seoul 147
Milan 123
Princeton 122
Boardman 105
Izmir 101
Dearborn 91
Chicago 83
Los Angeles 78
Rome 75
Trieste 72
Ho Chi Minh City 69
Dublin 65
Lauterbourg 62
Sofia 62
Moscow 59
Zgierz 58
Columbus 56
Hanoi 55
Buffalo 53
Santa Clara 51
The Dalles 49
Helsinki 42
Munich 41
Dallas 33
Düsseldorf 31
Verona 30
Turin 29
San Diego 28
New York 27
Frankfurt am Main 26
Naples 26
Brussels 25
Bologna 24
Council Bluffs 23
Kunming 23
Nanjing 23
Bari 22
London 22
Ottawa 22
Warsaw 19
Dakar 18
Florence 18
Venezia 18
Casablanca 17
Grafing 17
Shanghai 17
Venice 17
Cagliari 16
Tokyo 16
Turku 16
Des Moines 15
Guangzhou 15
Orem 15
São Paulo 15
Atlanta 14
Bremen 14
Haiphong 14
Mestre 14
Montreal 14
Phoenix 14
Redondo Beach 14
Chennai 12
Jinan 12
Redwood City 12
Shenyang 12
Tianjin 12
Pune 11
Washington 11
Auburn Hills 10
Da Nang 10
Denver 10
Falls Church 10
Hangzhou 10
Nuremberg 10
Catania 9
Miano 9
Nairobi 9
Palermo 9
Sydney 9
Toronto 9
Zhengzhou 9
Changsha 8
Grugliasco 8
Modena 8
Norwalk 8
Totale 8.869
Nome #
Continuità assistenziale ospedale-territorio per il paziente con scompenso cardiaco cronico: Una rivoluzione e una sfida nella cura ambulatoriale 1.158
Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study 397
Body composition and muscular strength changes after moderate activity: association with matrix metalloproteinase polymorphisms. 308
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 297
Carotid plaque vulnerability and matrix metalloproteinase -1 and -9 genetic polymorphisms 297
Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion. 293
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 281
D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. A 2-year follow-up. 276
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 267
Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase finctional polymorphisms. 263
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 255
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 253
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients 250
Remodeling in acute coronary syndromes: expectations and frustrations for risk assessment and therapy. 241
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 238
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 235
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 233
MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. 228
Disseminated tuberculosis in an immunocompetent patient 216
Mechanisms of malnutrition in uremia. 214
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 214
Insights into human hypertension: the role of endothelial dysfunction. 213
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. 205
Platelet function and clotting parameters of vibration-exposed foundry workers. 196
MMP-9 microsatellite polymorphism and multiple sclerosis. 195
Control of anticoagulant therapy with portable prothrombin time device in patients with mechanical heart valve prostheses: two-year follow-up 195
Regulation of energy balance and blood pressure: are genetic polymorphisms pertinent? 194
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. 191
Calciphylaxis of the breast: a rare disease in the differential diagnosis of breast cancer 189
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 187
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. 184
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. 184
Improving siRNA Bio-Distribution and Minimizing Side Effects 181
Genetic approaches to hypertension: relevance to human hypertension 179
Inborn prothrombotic states 179
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 175
Monitoring of hemostasis 174
The Integration of qSOFA with Clinical Variables and Serum Biomarkers Improves the Prognostic Value of qSOFA Alone in Patients with Suspected or Confirmed Sepsis at ED Admission 174
[Ximelagatran: a promising new drug for oral anticoagulation] 173
Treatment of intermittent claudication with antiplatelet agents. 171
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 168
Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study 166
[Disease management system in patients with chronic heart failure] 161
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 157
Relation of haemostatic function, neurovascular impairment, and vibration exposure in workers with different stages of vibration induced white finger 155
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 153
Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. 151
MMP-2 genetic variant and plaque features of instability 151
null 150
null 148
Evaluation of principal risk factors, hemorheological and blood coagulation characteristics in arteriosclerosis obliterans in the elderly 147
null 146
Role of E2F1–Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAs 144
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. 140
Psoriasis and endothelins. 138
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 136
Risk factors associated with early central nervous system damage detected through Diffusion Tensor Imaging (DTI) in patients with Systemic Lupus Erythematosus 134
Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study 134
Evaluation of bortezomib impact on cell-cycle related genes in the hepatocellular carcinoma cell lines hepg2 and jhh6 by means of microarray analysis 127
null 121
Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose 112
Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases 105
New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins 98
null 96
Short term effects of doxycycline on matrix metalloproteinases 2 and 9. 86
null 73
Prostate Tumour-Inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection 67
[Clinical practice: Ebstein's anomaly] 1
Totale 13.518
Categoria #
all - tutte 35.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 0 96
2021/2022924 40 62 43 129 31 94 28 45 109 102 75 166
2022/20231.350 120 134 114 192 148 220 44 108 160 19 61 30
2023/2024798 61 65 44 56 97 73 84 119 19 42 71 67
2024/20251.496 34 47 85 132 188 148 107 94 203 177 119 162
2025/20263.266 332 191 226 310 267 324 460 77 351 472 109 147
Totale 13.518